H&Q Asia Pacific

FST Network's product helps enterprises to manage and integrate their data efficiently by providing an IAM solution for cross-system communication and simplifying complex data structure and rules structure that can be utilized for a more efficient CRM solution. Our product enables de-identification protection, access gateway, and accountable network to ensure security for cross-system communication provided with seamless integrations via APIs

Hyphen Group operates as CompareAsiaGroup, a prominent personal finance management platform in Asia. Established in 2014 and headquartered in Hong Kong, the Group provides a comprehensive, free, and independent online service for comparing financial products, including banking, insurance, and telecommunications. With partnerships with leading financial institutions, it offers access to over 2,500 products, helping consumers make informed choices and save money. The Group has a significant presence across multiple countries in Asia, including Malaysia, the Philippines, Singapore, Taiwan, and Thailand, employing over 250 individuals dedicated to enhancing personal finance management for users.

Viscovery is an advanced artificial intelligence company specializing in image and video recognition through deep learning and computer vision technologies. Founded in 2013, the company has established partnerships with major technology firms and has garnered international investment from notable entities. Viscovery offers tailored recognition solutions across various sectors, including smart retail, e-commerce, media, augmented reality, and smart manufacturing. The company’s research and development team, based in Taipei, consists of experts in artificial intelligence and machine learning, dedicated to exploring innovative applications of vision AI. Through its comprehensive visual discovery services, Viscovery aims to enhance enterprise operations and customer experiences.

Senhwa Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Founded in 2012 and headquartered in New Taipei City, Taiwan, the company is advancing several drug candidates through clinical trials. Notably, CX-4945 is undergoing phase I/II trials for cholangiocarcinoma in combination with gemcitabine and cisplatin, while CX-5461 is being tested in phase I studies for advanced hematologic malignancies and solid tumors, including breast cancer. Additionally, CX-4945 is involved in trials for advanced basal cell carcinoma and recurrent SHH medulloblastoma through pediatric brain tumor consortium studies. Senhwa Biosciences aims to identify and develop therapies that have the potential to significantly enhance treatment outcomes for patients, focusing on underexploited targets that could improve the standard of care.

Ralink Technology Corporation specializes in the development of integrated circuit (IC) and semiconductor products tailored for networking, broadband, consumer electronics, and computing applications. The company offers a range of Wi-Fi home networking solutions, including USB and PCI solutions for wireless devices, as well as access points, routers, and intelligent network interface cards. Ralink's product portfolio also includes chipsets for xDSL and ADSL customer premises equipment, facilitating a variety of communication technologies. Its innovative chipsets are recognized for their high throughput, extended range, and low power consumption, catering to mobile and embedded applications. Ralink's technologies, such as MIMObility and Video Turbine, enhance Wi-Fi capabilities across diverse devices, including personal computers, digital televisions, and gaming systems. Founded in 2001 and headquartered in Hsinchu Hsien, Taiwan, Ralink operates as a subsidiary of MediaTek Inc. and serves customers across the Americas, Europe, and Asia through authorized distributors.

Semiconductor Manufacturing International Corporation (SMIC) is a semiconductor foundry providing integrated circuit (IC) foundry and technology services at 0.35-micron to 40-nanometer. SMIC develops one-stop turnkey services to meet its customers’ needs. In addition to IC manufacturing, SMIC offers a full range of services that includes design services, mask manufacturing, and testing. SMIC provides integrated circuit (IC) foundry and technology services on process nodes from 0.35 micron to 28 nanometer. Headquartered in Shanghai, China, SMIC has an international manufacturing and service base. In China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai; a 300mm mega-fab and a majority-owned 300mm fab for advanced nodes in Beijing; 200mm fabs in Tianjin and Shenzhen; and a majority-owned joint-venture 300mm bumping facility in Jiangyin; additionally, in Italy SMIC has a majority-owned 200mm fab. Headquartered in Shanghai, China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai, a 300mm mega-fab in Beijing, a 200mm fab in Tianjin, and a 200mm fab project under development in Shenzhen. SMIC also has customer service and marketing offices in the U.S., Europe, Japan, and Taiwan, and a representative office in Hong Kong. SMIC competes with Taiwan Semiconductor Manufacturing Company, Ltd., United Microelectronics Corporation, GlobalFoundries, Fujitsu Limited, Samsung Electronics Co., Ltd., and Toshiba Corporation.